MEDGm vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 1, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

53 providers verified independently·Independent research·How we rank →

Short answer: Willow scores higher on our rubric, 7.5/10 against 2.7/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Willow - our pick of these two →or find your match

Willow beats MEDGm overall, scoring 7.5/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: MEDGm is from $179/mo; Willow is from $299/mo. Choose MEDGm for shoppers who want a compounded glp-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named. Choose Willow for users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide.

A side-by-side look at MEDGm and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

MEDGm

#53 of 53

2.7/10

MEDGm is a telehealth company selling compounded GLP-1 injections from $179/mo and dissolvable tablets from $249/mo, with brand-name Zepbound, Wegovy and Ozempic offered as a membership plus an unpublished medication cost. The compounded prices are readable before intake and the not-FDA-approved disclosure is prominent, which is more than several better-known programs manage. The gap is verification: no clinician, no pharmacy and no accreditation is named anywhere on the site or in its terms.

Visit MEDGm

Higher Rated

Willow

#18 of 53

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Offers daily oral tablets for BOTH molecules alongside the injectables, semaglutide tablets and tirzepatide tablets, at the same price as the corresponding injection.

Visit Willow

Feature	MEDGm	Willow
Why each one	Publishes its compounded prices before intake and does not claim an accreditation it cannot support. Both are low bars that a surprising number of programs fail.	The only compounded platform on our index with daily oral tablets for BOTH semaglutide and tirzepatide at injection-price parity, the widest needle-free menu in the compounded category.
Our Score	2.7/10	7.5/10
Headline Price	from $179/mo	from $299/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Shoppers who want a compounded GLP-1 with the price visible before intake and are comfortable that no clinician or pharmacy is named.	Users who want comprehensive clinical support with a needle-free daily tablet option on both semaglutide and tirzepatide
Watch out for	No medical director, prescribing clinician or medical group is named anywhere	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#53	#18
Get started	Visit MEDGm	Visit Willow

Pros & Cons Compared

MEDGm

Pros

+Compounded prices visible on the landing page without starting an intake
+Prominent, correctly-worded disclosure that compounded GLP-1s are not FDA-approved
+Cancel any time, with a published refund policy rather than a buried one
+Claims no accreditation it cannot support, which is rarer than it should be
+HSA/FSA accepted; free shipping stated

Cons

−No medical director, prescribing clinician or medical group is named anywhere
−No compounding pharmacy is named; the terms promise a partner list that the terms do not contain
−Brand-name Zepbound, Wegovy and Ozempic are priced as a membership plus an unpublished medication cost, so no brand total can be compared
−No lab panel is offered or required at any tier
−The homepage claims 120,000+ patients on a domain registered 2026-04-08; we could not reconcile the two
−A prepaid contracted term is non-refundable, and dispensed medication is never refundable
−No third-party rating exists that we could locate and verify

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Daily oral tablets for BOTH semaglutide and tirzepatide, one of the only platforms with a needle-free route on both molecules
+$299/mo all-in for compounded semaglutide (injectable or tablet) with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide runs $399/mo against $299 for semaglutide, a $100/mo premium for the dual-pathway molecule
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out MEDGm with a score of 7.5/10 vs 2.7/10. Published pricing is not a like-for-like monthly comparison: MEDGm is from $179/mo; Willow is from $299/mo. MEDGm offers both brand-name and compounded medications, giving you more flexibility.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both MEDGm and Willow start above the cheapest complete recurring program we track. Across all 53 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.